A compound of formula (1), or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof: and pharmaceutical compositions comprising these, all for use in the treatment of chemokine mediated diseases and disorders.
公式(1)的化合物,或其药学上可接受的盐,溶剂或体内可
水解的
酯;以及包含这些化合物的制药组合物,均用于治疗
趋化因子介导的疾病和障碍。